TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

COVID-19-treatment

World 5 years ago

Canada OKs remdesivir for use against coronavirus

Canada on Tuesday gave the green light for people with severe symptoms of COVID-19 to be treated with the anti-viral drug remdesivir.

World 5 years ago

Moderna's COVID-19 vaccine candidate moves into late-stage trial

Moderna Inc said on Monday it had started a late-stage trial to test the effectiveness of its COVID-19 vaccine candidate, the first such study under the Trump administration's program to speed development of measures against the novel coronavirus.

News 5 years ago

Emirates to cover virus-related medical costs

Emirates, the largest airline in the Middle East, will cover customers' coronavirus-related medical costs in a bid to "boost travel confidence", the Dubai Media Office said Thursday.

World 5 years ago

China's Sinopharm says coronavirus vaccine could be ready by year-end: State media

A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday, ahead of a previous expectation it may become available in 2021.

World 5 years ago

Glenmark's favipiravir version shows promise in late-stage COVID-19 trial

India's Glenmark Pharmaceuticals Ltd said on Wednesday its version of anti-flu drug favipiravir showed promise in a late-stage study of 150 patients with mild to moderate coronavirus infection.

World 5 years ago

Pakistanis risk unproven plasma treatment in virus fight

Pakistanis with COVID-19 are risking their lives and navigating a shady black market to get blood plasma transfusions, despite scant medical proof about the remedy's effectiveness.

World 5 years ago

Japan approves dexamethasone as coronavirus treatment

Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalized patients.

World 5 years ago

Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trial

German biotech BioNTech and US drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.

World 5 years ago

'Breakthrough' treatment slashes virus death risk: Study

An aerosol-based treatment could drastically reduce the number of new coronavirus patients dying from the disease or requiring intensive care, according to preliminary results released Monday by a British biotech firm.

World 5 years ago

Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva

Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech, and French group Valneva, the business ministry said on Monday.

TheJakartaPost

Popular Reads

Top Results

Popular Reads

Top Results

LOG IN

COVID-19-treatment

Canada OKs remdesivir for use against coronavirus

Moderna's COVID-19 vaccine candidate moves into late-stage trial

Emirates to cover virus-related medical costs

China's Sinopharm says coronavirus vaccine could be ready by year-end: State media

Glenmark's favipiravir version shows promise in late-stage COVID-19 trial

Pakistanis risk unproven plasma treatment in virus fight

Japan approves dexamethasone as coronavirus treatment

Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trial

'Breakthrough' treatment slashes virus death risk: Study

Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva

follow our Social media